Guangzhou (1)

Non Hodgkin Lymphoma (1)

PCNSL (1)

Refractory and Relapsed Primary CNS Lymphoma (1)

Not yet recruiting (1)

phase 1/phase 2 (1)

Huiqiang Huang (1)

Guangdong 999 Brain Hospital (1)

orelabrutinib (1)

thiotepa (1)

drug (1)

Other (1)

Interventional (1)

refractory and relapsed primary cns lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Guangzhou, Guangdong, China

Department of Medical Oncology, Sun Yat-sen University Cancer Ce

Aug 19, 2021